ConductScience.org, home

Trial · NCT01962870

Outcomes21

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYChange From Baseline in Parent Rated Social Responsiveness Scale, 2nd Edition (SRS-2) T-Score After Treatment.Baseline; Week 4Participants who completed the protocol are included in the analysis.units on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Clinical Global Impression (CGI) Severity, Social and Communication Scores During Treatment.Baseline; Week 4Participants with available data are included.units on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Reading the Mind in the Eyes Test, Child Version (RMET-child) Scores During Treatment.Baseline; Week 4Participants with available data are included in the analysis.units on a scaleMEAN
SECONDARYChange From Baseline in Laboratory Based Facial Emotion Recognition Abilities During Treatment.Baseline; Week 4Participants with available data are included in the analysis.units on a scaleMEAN
SECONDARYChange From Baseline in Parent Rated Repetitive Behavior Scale Revised (RBS-R) Scores During Treatment.Baseline; Week 4Participants with available data were analyzed.units on a scaleMEAN
SECONDARYChange From Baseline in Parent Rated Spence Children's Anxiety Scale (SCAS) During Treatment.Baseline; Week 4Participants with available data were analyzed.units on a scaleLEAST_SQUARES_MEAN
SECONDARYNumber of Participants With Side Effects Assessed Using Parent Rated Dosage Record Treatment Emergent Symptom Scale (DOTES) Scores During TreatmentBaseline through Week 4Participants who completed the protocol are included in the analysis.participantsNUMBER
SECONDARYChange From Baseline on the Overt Aggression Scale (OAS) During Treatment.Baseline through Week 4Participants with available data are included in the analysis.ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYChange From Baseline in Heart Rate After Treatment.Baseline; Week 4Participants who completed the protocol are included in the analysis.Beats per minuteLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Parent Rated Aberrant Behavior Checklist (ABC) Scores During Treatment.Baseline; Week 4Participants with available data were included in analysis.units on a scaleMEAN
SECONDARYChange From Baseline in Parent Rated Pediatric Quality of Life (PedQL) Inventory Scores During Treatment.Baseline; Week 4Participants with available data were analyzed.units on a scaleMEAN
SECONDARYChange From Baseline in Parent Rated Vineland Adaptive Behavior Scales Second Edition (VABS-II) - Social and Communication Subscales During Treatment.Baseline; Week 4Not all participants were able to fully complete the measure so not all of the numbers analyzed are the same.units on a scaleMEAN
SECONDARYChange From Baseline in Clinical Chemistry Labs (NA+, K+, Cl-) During Treatment.Baseline; Week 4Participants with available data are included in the analysis.mmol/LLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Laboratory Based Eye-gaze to Social Cues During Treatment.Baseline; Week 4Data were not not collected for this outcome.
SECONDARYChange From Baseline in Laboratory Based Social Mimicry Abilities During Treatment.Baseline; Week 4Data were not not collected for this outcome.
SECONDARYChange From Baseline in Blood Pressure After TreatmentBaseline; Week 4Participants with available data are included in the analysis.mmHGLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Body Weight After Treatment.Baseline; Week 4Participants with available data are included in the analysis.kilogramsLEAST_SQUARES_MEAN
SECONDARYChange From Baseline in Body Temperature After TreatmentBaseline; Week 4Participants with available data are included in the analysis.Degrees (Farenheit)LEAST_SQUARES_MEAN
SECONDARYChange From Baseline in the Awareness of Social Inference Test Revised (TASIT-R) Scores During Treatment.Baseline, Week 4Data were not not collected for this outcome.
SECONDARYChange From Baseline in a Developmental Neuropsychological Assessment, Second Edition. (NEPSY-II) Affect Recognition Scores During Treatment.Baseline; Week 4Participants with available data were included.units on a scaleLEAST_SQUARES_MEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01962870/outcomes